Assist Prof Dr. Maryam Ghiyasiyan-Arani | Authentic Leadership | Young Scientist Award

Assist Prof Dr. Maryam Ghiyasiyan-Arani | Authentic Leadership | Young Scientist Award

 

Tsinghua University, China

Profile 

Google Scholar 

🎓 Early Academic Pursuits

Maryam Ghiyasiyan-Arani began her academic journey with a Bachelor of Science in Pure Chemistry at Kashan University (2010-2014), where she demonstrated remarkable academic prowess, ranking 1st in her class with a GPA of 18.09/20. Following this success, she pursued a Master of Science in Nanoscience and Nanotechnology (Nanochemistry) at the same institution from 2014 to 2016, again ranking 1st in her class with an even higher GPA of 19.35/20. Her interest in nanotechnology and materials science became evident during her MSc studies, where her thesis focused on the synthesis, characterization, and investigation of nanomaterials like vanadates of metals such as Copper(II), Nickel(II), and Cobalt(II) for photocatalytic and optical properties.

Continuing her academic pursuit, she earned her Ph.D. in Nanoscience and Nanotechnology from Kashan University (2016-2020), where she once again ranked at the top of her class. Her doctoral research explored the electrochemical performance of lithium-ion batteries (LIBs) and hydrogen storage materials, particularly focusing on vanadate, niobate, and spinel nanostructures. Her Ph.D. work was supported by industrial collaborations with the Power Energy Organization and Saba Battery Company, indicating her work’s relevance to real-world energy applications.

🧑‍🔬 Professional Endeavors

Dr. Ghiyasiyan-Arani is currently a faculty member at the Institute of Nanoscience and Nanotechnology, University of Kashan, where she continues her research and mentorship in nanotechnology. Her career is marked by an impressive array of projects focusing on nanomaterials for energy storage, particularly hydrogen storage and lithium-ion batteries. She has been involved in several research projects, including the synthesis of active materials for energy storage, investigation of clay as a hydrogen storage material, and the design of separators for lithium-ion batteries.

Beyond her academic roles, she is a member of several prestigious organizations, including the Iran Nanotechnology Initiative Council (INIC), Young Research and Elite Club, and Iran’s National Elites Foundation, reflecting her recognition as a leading figure in nanoscience.

🔬 Contributions and Research Focus

Dr. Ghiyasiyan-Arani has made significant contributions to the field of nanotechnology, with a strong focus on energy storage materials and environmental applications. Her research interests include:

Synthesis and Characterization of Nanomaterials: She specializes in creating nanomaterials with different morphologies using various chemical methods like precipitation, sonochemistry, microwave, hydrothermal, and sol-gel synthesis.
Electrochemical Hydrogen Storage: A major focus of her work involves improving the capacity of nanomaterials for hydrogen storage, a crucial area for clean energy technologies.
Lithium-Ion Batteries: Her work on LIBs extends to synthesizing active materials (both cathode and anode), designing battery separators, and studying the electrochemical properties of batteries through techniques like impedance spectrometry, galvanostatic charge-discharge, and cyclic voltammetry.
Water Treatment: She is also exploring photocatalytic activities of nanomaterials for water treatment, indicating her focus on environmental sustainability.

🏅 Accolades and Recognition

Dr. Ghiyasiyan-Arani has earned numerous accolades throughout her career. Some notable recognitions include:

Stanford University Top 2% Scientists Worldwide: She was listed among the Top 2% Scientists Worldwide in 2022 and 2023 by Stanford University, highlighting the global impact of her work.
Reviewer of Prestigious Journals: She serves as a reviewer for several ISI-indexed journals like Ultrasonics Sonochemistry, Journal of Alloys and Compounds, International Journal of Hydrogen Energy, and Nanoscale Advances, which reflects her expertise and standing in the academic community.
Reviewer for International Congress on Nanoscience and Nanotechnology: She has also reviewed work for major conferences such as the 7th International Congress on Nanoscience and Nanotechnology (ICNN2018), further contributing to the growth of nanoscience.

🌍 Impact and Influence

Dr. Ghiyasiyan-Arani’s work is particularly impactful in the field of clean energy. Her focus on hydrogen storage materials and lithium-ion batteries positions her research at the forefront of the global push towards sustainable energy solutions. Her publications on electrochemical hydrogen storage and battery materials have added significant insights to the scientific community, advancing the development of more efficient and environmentally friendly energy storage technologies.

Additionally, her contributions to photocatalytic water treatment show her dedication to addressing environmental issues, particularly in developing sustainable methods for cleaning water, a critical resource in a world facing climate change.

🏛️ Legacy and Future Contributions

Dr. Maryam Ghiyasiyan-Arani is poised to leave a lasting legacy in the fields of nanotechnology and energy storage. As a leading researcher in Iran and a globally recognized scientist, her continued work will likely contribute to critical advancements in renewable energy technologies and environmental sustainability. With her ongoing involvement in academia and collaborations with industrial partners, her future contributions are expected to further bridge the gap between fundamental research and practical, real-world applications.

In the coming years, she is likely to make strides in developing next-generation energy storage systems and green technologies, contributing to global efforts to combat climate change and reduce reliance on fossil fuels. Her innovative approaches to nanomaterial synthesis and energy storage position her as a key player in the ongoing evolution of sustainable energy solutions.

📝Notable Publications

Dr. Silvia Cingelova | Authentic Leadership | Best Researcher Award

Dr. Silvia Cingelova | Authentic Leadership | Best Researcher Award

National Cancer Institute, Slovakia

Profile 

Google Scholar 

Early Academic Pursuits 🎓

Dr. Silvia Cingelová’s journey into the world of medicine and oncology began with a solid academic foundation, characterized by her unwavering commitment to education and excellence. She embarked on her academic career at the Faculty of Medicine, Comenius University in Bratislava, Slovakia, where she earned her MUDr. (Doctor of Medicine) degree in 2004. This achievement marked the beginning of a promising career in the medical field.

Her thirst for knowledge and her desire to expand her expertise led her to pursue further education. She obtained a Master’s degree with the academic title Ing. from the Faculty of Economic Informatics at The University of Economics in Bratislava in 2007. This multidisciplinary approach provided her with a unique perspective, blending medical knowledge with economic and informatics skills, equipping her to address the complexities of healthcare management and patient care in innovative ways.

In addition to her medical degree, Dr. Cingelová also completed postgraduate studies at the Vienna School of Clinical Research in Austria between 2005 and 2007. Her education continued with the pursuit of a PhD at the Faculty of Health Sciences and Social Work at the University of Trnava, Slovakia, where she deepened her research skills and focused on health sciences, completing this in 2013. Her diverse academic background laid a strong foundation for her future endeavors in the field of oncohematology.

Professional Endeavors 💼

Dr. Cingelová’s professional journey is a testament to her dedication and expertise in the field of oncohematology. After earning her M.D., she began her career as a junior physician at the Oncology Clinics in Trnava, Slovakia, where she worked from 2004 to 2013. During this time, she honed her skills in diagnosing and treating various forms of cancer, gaining invaluable experience in the intricacies of oncology.

In 2013, she transitioned to the Národný onkologický ústav (National Cancer Institute) in Bratislava, Slovakia, where she took on the role of an Oncohematologist in the Department of Oncohematology II. Her work in this prestigious institution has allowed her to focus on the treatment and research of blood cancers, including leukemia, lymphoma, and myeloma. Dr. Cingelová’s dedication to patient care, coupled with her comprehensive knowledge of hematologic malignancies, has made her a key figure in the department, contributing to both clinical practice and ongoing research.

Contributions and Research Focus 🧬

Dr. Cingelová’s research interests are deeply rooted in the field of oncohematology, where she has made significant contributions to understanding the complexities of hematologic cancers. Her work is characterized by a commitment to improving patient outcomes through innovative treatment approaches and the integration of clinical research into everyday practice. Her PhD work, combined with her clinical experience, has positioned her as a thought leader in her field, with a focus on translational research that bridges the gap between laboratory discoveries and clinical application.

Her research is not limited to the lab; she actively participates in clinical trials, evaluating new therapies and treatment protocols that could potentially revolutionize the management of blood cancers. By contributing to groundbreaking studies, Dr. Cingelová is at the forefront of advancing the field of oncohematology, providing patients with access to the latest and most effective treatment options.

Accolades and Recognition 🏆

Throughout her career, Dr. Cingelová has received numerous accolades that recognize her contributions to medicine and research. Her achievements in both clinical practice and research have earned her a reputation as a leading expert in oncohematology. Colleagues and patients alike commend her for her dedication, compassion, and relentless pursuit of excellence.

Dr. Cingelová’s work has been acknowledged not only within Slovakia but also on an international level. Her participation in international conferences and collaborations has brought her recognition in the global medical community, further solidifying her standing as an expert in her field. These accolades are a testament to her impact and influence in the medical community, particularly in the realm of cancer treatment and research.

Impact and Influence 🌍

Dr. Cingelová’s impact extends far beyond her immediate work environment. As an oncohematologist, her influence is seen in the improved outcomes of countless patients who have benefited from her expertise. She is known for her patient-centered approach, which emphasizes compassionate care and individualized treatment plans. This approach has not only improved patient satisfaction but also contributed to better clinical outcomes.

Her influence is also evident in the mentorship she provides to younger physicians and medical students. Dr. Cingelová is committed to sharing her knowledge and experience with the next generation of healthcare professionals, ensuring that her legacy of excellence continues through those she has trained and inspired.

Legacy and Future Contributions 🌟

Looking ahead, Dr. Cingelová is poised to continue making significant contributions to the field of oncohematology. Her ongoing research and clinical work will undoubtedly lead to new insights and advancements in the treatment of blood cancers. As she continues to mentor the next generation of physicians and engage in cutting-edge research, her legacy will be one of innovation, compassion, and unwavering dedication to the fight against cancer.

In the years to come, Dr. Cingelová’s work will likely influence the direction of oncohematology, shaping the future of cancer care. Her legacy will be defined not only by her professional achievements but also by the lives she has touched through her compassionate care and commitment to advancing medical science.

Publications 

Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer

Authors: Z Cierna, M Mego, P Janega, M Karaba, G Minarik, J Benca, et al.

Journal: BMC Cancer

Volume: 14

Issue: Not specified (article number)

Pages: 1-8

Year: 2014

CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer

Authors: M Mego, D Cholujova, G Minarik, T Sedlackova, P Gronesova, M Karaba, et al.

Journal: BMC Cancer

Year: 2016

Long-term cognitive functioning in testicular germ-cell tumor survivors

Authors: M Chovanec, L Vasilkova, L Setteyova, J Obertova, P Palacka, et al.

Journal: The Oncologist

Year: 2018

Plasma cytokines correlated with disease characteristics, progression-free survival, and overall survival in testicular germ-cell tumor patients

Authors: D Svetlovska, V Miskovska, D Cholujova, P Gronesova, S Cingelova, et al.

Journal: Clinical Genitourinary Cancer

Year: 2017

The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer

Authors: Z Sestakova, K Kalavska, L Hurbanova, D Jurkovicova, J Gursky, et al.

Journal: Oncotarget

Year: 2016

Plasma thiobarbituric acid reactive substances predicts survival in chemotherapy naïve patients with metastatic urothelial carcinoma

Authors: J Slopovsky, J Kucharska, J Obertova, M Mego, K Kalavska, S Cingelova, et al.

Journal: Translational Oncology

Year: 2021